By Dr Reuben Carr, Technology Commercialisation Manager, NCIMB Ltd. Acquiring precision genetic alignment between strain design and biological reality can be a challenge for microbial strain engineers. NCIMB’s technology commercialisation manager Dr Reuben Carr considers what is at stake, and the steps that can be taken to tackle this important issue. Precision engineered microbes provide sustainable and low carbon routes to the production of essential chemical feedstocks. They contribute billions to the global economy and help achieve industrial net zero targets. Whilst some precision engineered microbes are already put to …
NCIMB Ltd kicks-off innovative enzyme technology development project with potential application in medicines and environmental remediation.
Aberdeen-based biotechnology company NCIMB has kicked-off a new research project to demonstrate novel enzyme technology with an exciting array of potential applications in the pharmaceutical, food & drink and environmental sectors. The work is being supported with a Bio-based Manufacturing in Scotland grant from Innovate UK. The project targets the production of a molecule called cyclodextrin – something that many people will have encountered in their day-to-day lives without realising it. Cyclodextrins are natural products made from starch, using enzymes produced by bacteria, and this project focuses on the enzyme …